More work is required to better dissect tumor-promoting from tumor suppressing roles conferred by the IL33-ST2 axis in order to predict in which tumor microenvironment inhibition of IL33-ST2 signaling or MCs will be beneficial. The gene discussed is IL33; the disease is neoplasm.